Background: Atopic dermatitis (AD) is significantly associated with keratoconus (KC). An inherited component for KC has been suggested. Filaggrin (FLG) mutations are a strong genetic risk factor for AD. Since filaggrin is also expressed in the corneal epithelium, we hypothesized a common aetiology for ichthyosis vulgaris (IV), AD and KC. Objectives: We examined the prevalence of AD and IV in a KC population. We also studied the expression of filaggrin in normal and KC cornea and analysed 2 prevalent loss-of-function FLG alleles (R501X and 2282del4) in a KC population. Finally we examined whether the population with KC and FLG mutations had specific clinical characteristics. Results: Of 89 KC patients, 38 had current or a history of AD and/or IV. Five patients were carriers of at least 1 FLG mutant allele and had a clinical diagnosis of AD and IV with a severer KC. Conclusion: The low frequency of FLG mutations is surprising since 42.7% of our KC population had AD associated or not with IV; the expected frequency would have been 12–15%, based on our previous studies. Further studies are required to look at other possible FLG mutations or other candidate genes.

Keywords:
Filaggrin, Atopic dermatitis, Keratoconus
1.
Rabinowitz YS: Keratoconus. Surv Ophtalmol 1998;42:297–319.
2.
Copeman PW: Eczema and keratoconus. Br Med J 1965;ii:977–979.
3.
Gasset AR, Hinson WA, Frias JL: Keratoconus and atopic diseases. Ann Ophthalmol 1978;10:991–994.
4.
Harrison RJ, Klouda PT, Easty DL, Manku M, Charles J, Stewart CM: Association between keratoconus and atopy. Br J Ophthalmol 1989;73:816–822.
5.
Ohmachi N, Sasabe T, Kojima M, Adachi J, Endo K, Fukuzumi T, Aoki T: Eye complications in atopic dermatitis. Arerugi 1994;43:796–799.
6.
Bawazeer AM, Hodge WG, Lorimer B: Atopy and keratoconus: a multivariate analysis. Br J Ophtalmol 2000;84:834–836.
7.
Kaya V, Karakaya M, Utine CA, Albayrak S, Oge OF, Yilmaz OF: Evaluation of the corneal topographic characteristics of keratoconus with orbscan II in patients with and without atopy. Cornea 2007;26:945–948.
8.
Taïeb A: Hypothesis: from epidermal barrier dysfunction to atopic disorders. Contact Dermatitis 1999;41:177–180.
9.
Smith FJ, Irvine AD, Terron-Kwiatkowski A, Sandilands A, Campbell LE, Zhao Y, et al: Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 2006;38:337–342.
10.
Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al: Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441–446.
11.
Weidinger S, Illig T, Baurecht H, Irvine AD, Rodriguez E, Diaz-Lacava A, et al: Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006;118:214–219 (erratum published in J Allergy Clin Immunol 2006;118:b922, 2006;118:724).
12.
Marenholz I, Nickel R, Rüschendorf F, Schulz F, Esparza-Gordillo J, Kerscher T, et al: Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 2006;118:866–871.
13.
Ruether A, Stoll M, Schwarz T, Schreiber S, Fölster-Holst R: Filaggrin loss-of-function variant contributes to atopic dermatitis risk in the population of Northern Germany. Br J Dermatol 2006;155:1093–1094.
14.
Barker JN, Palmer CN, Zhao Y, Liao H, Hull PR, Lee SP, et al: Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol 2007;127:564–567.
15.
Stemmler S, Parwez Q, Petrasch-Parwez E, Epplen JT, Hoffjan S: Two common loss-of-function mutations within the filaggrin gene predispose for early onset of atopic dermatitis. J Invest Dermatol 2007;127:722–724.
16.
Hubiche T, Ged C, Benard A, Léauté-Labrèze C, McElreavey K, de Verneuil H, Taïeb A, et al: Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort. Acta Derm Venereol 2007;87:499–505.
17.
Weidinger S, Rodríguez E, Stahl C, Wagenpfeil S, Klopp N, Illig T, et al: Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J Invest Dermatol 2007;127:724–726.
18.
Weidinger S, O’Sullivan M, Illig T, Baurecht H, Depner M, Rodriguez E, Ruether A, et al: Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol 2008;121:1203–1209.
19.
Hanifin JM: Filaggrin mutations and allergic contact sensitization. J Invest Dermatol 2008;128:1362–1364.
20.
Brown SJ, McLean WH: Eczema genetics: current state of knowledge and future goals. J Invest Dermatol 2009;129:543–552.
21.
Greisenegger E, Novak N, Maintz L, Bieber T, Zimprich F, Haubenberger D, et al: Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2010;24:607–610.
22.
Rodriguez E, Baurecht H, Herberich E, Wagenpfeil S, Brown SJ, Cordell HJ, et al: Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic dermatitis. J Allergy Clin Immunol 2009;123:1360–1370.
23.
Schuttelaar ML, Kerkhof M, Jonkman MF, Koppelman GH, Brunekreef B, de Jongste JC, et al: Filaggrin mutations in the onset of eczema, sensitization, asthma, hay fever and the interaction with cat exposure. Allergy 2009;64:1758–1765.
24.
Tong L, Corrales RM, Chen Z, Villarreal AL, De Paiva CS, Beuerman R, et al: Expression and regulation of cornified envelope proteins in human corneal epithelium. Invest Ophthalmol Vis Sci 2006;47:1938–1946.
25.
Williams HC, Burney PG, Pembroke AC, Hay RJ: The UK Working Party’s diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol 1994;131:406–416.
26.
Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A: Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997;195:10–19.
27.
Sandilands A, Terron-Kwiatkowski A, Hull PR, O’Regan GM, Clayton TH, Watson RM, et al: Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis and atopic eczema. Nat Genet 2007;39:650–654.
28.
Akiyama M: FLG mutations in ichthyosis vulgaris and atopic eczema: spectrum of mutations and population genetics. Br J Dermatol 2010;162:472–477.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.